Serum Institute of India applies to DCGI to manufacture Covid vaccine Sputnik V
New Delhi, June 3 The Serum Institute of India (SII) has applied to the Drug Controller General of India (DCGI) seeking permission to manufacture COVID-19 vaccine Sputnik V in the country, sources said on Thursday. The Pune-based firm has also sought approval for test analysis and examination. Russia’s Sputnik VRead More